Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) - Global Forecasts to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1               MARKETS COVERED.. 15
1.3.2               YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            LIMITATIONS
1.6            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1               SECONDARY DATA
2.1.1.1             KEY DATA FROM SECONDARY SOURCES
2.1.2               PRIMARY DATA
2.1.2.1             KEY DATA FROM PRIMARY SOURCES
2.1.2.2             KEY INDUSTRY INSIGHTS
2.2            MARKET SIZE ESTIMATION
2.2.1               BOTTOM-UP APPROACH
2.2.2               TOP-DOWN APPROACH.. 23
2.3            MARKET BREAKDOWN AND DATA TRIANGULATION
2.4            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            HEALTHCARE DISTRIBUTION SERVICES: MARKET OVERVIEW
4.2            NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE (2018)
4.3            EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER (2018)
4.4            HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1               DRIVERS
5.2.1.1             HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF CHRONIC DISEASES. 35
5.2.1.2             FAVORABLE R&D INVESTMENT SCENARIO AND SUBSEQUENT INCREASE IN DRUG LAUNCHES
5.2.1.3             GROWTH OF TRACK & TRACE SOLUTIONS
5.2.1.4             GROWING IMPORTANCE OF GENERICS
5.2.1.5             GROWTH OF THE MEDICAL DEVICES INDUSTRY
5.2.2               OPPORTUNITIES
5.2.2.1             GROWTH IN THE BIOSIMILARS MARKET
5.2.2.2             EMERGING MARKETS
5.2.2.3             INCREASING SPECIALTY DRUG DISPENSING
5.2.2.4             INCREASING UPTAKE OF BIOPHARMACEUTICALS
5.2.3               CHALLENGES
5.2.3.1             PRICING PRESSURES

6.... HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE

6.1            INTRODUCTION
6.2            PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES
6.2.1               OVER-THE-COUNTER DRUGS/VITAMINS
6.2.1.1             SALES OF OTC DRUGS HAVE RISEN DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS
6.2.2               BRAND-NAME/INNOVATOR DRUGS
6.2.2.1             RISING DEMAND FOR PRESCRIPTION DRUGS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
6.2.3               GENERIC DRUGS
6.2.3.1             GOVERNMENT INITIATIVES FOR PROMOTING THE USAGE OF GENERICS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
6.3            MEDICAL DEVICE DISTRIBUTION SERVICES. 49
6.4            BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES
6.4.1               MONOCLONAL ANTIBODIES
6.4.1.1             INCREASING INCIDENCE OF CANCER TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT. 52
6.4.2               VACCINES
6.4.2.1             GROWING PREVALENCE OF INFECTIOUS DISEASES HAS BOOSTED VACCINE DEVELOPMENT
6.4.3               RECOMBINANT PROTEINS
6.4.3.1             GROWING APPLICATIONS OF RECOMBINANT PROTEINS IN BIOPHARMACEUTICALS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.4.4               BLOOD AND BLOOD PRODUCTS
6.4.4.1             INCREASING NUMBER OF BLOOD DONATIONS AND BLOOD TRANSFUSIONS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
6.4.5               OTHER PRODUCTS

7.... HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER

7.1            INTRODUCTION
7.2            RETAIL PHARMACIES
7.2.1               LARGE VOLUME OF PRESCRIPTIONS TO INCREASE THE DEMAND FOR HEALTHCARE DISTRIBUTION SERVICES. 60
7.3            HOSPITAL PHARMACIES
7.3.1               SIGNIFICANT NUMBER OF INPATIENT VISITS AND REQUIREMENT OF LARGE VOLUME OF DRUGS BY HOSPITALS TO DRIVE THE HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES
7.4            OTHER END USERS

8.... HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION

8.1            INTRODUCTION
8.2            NORTH AMERICA
8.2.1               US
8.2.1.1             US DOMINATES THE NORTH AMERICAN HEALTHCARE DISTRIBUTION SERVICES MARKET
8.2.2               CANADA
8.2.2.1             RISING PREVALENCE OF CHRONIC DISEASES AND INCREASING MARKET FOR SPECIALTY DRUGS WILL DRIVE MARKET GROWTH IN CANADA
8.3            EUROPE
8.3.1               GERMANY
8.3.1.1             GERMANY ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018
8.3.2               FRANCE
8.3.2.1             PRESENCE OF LEADING PHARMACEUTICAL COMPANIES IN THE COUNTRY WILL DRIVE MARKET GROWTH IN FRANCE
8.3.3               UK
8.3.3.1             GROWTH IN THE PHARMACEUTICALS MARKET AND INCREASE IN RESEARCH ACTIVITY WILL DRIVE MARKET GROWTH IN THE UK
8.3.4               REST OF EUROPE
8.4            ASIA PACIFIC
8.4.1               CHINA AND INDIA ARE THE FASTEST-GROWING MARKETS IN THE APAC
8.5            REST OF THE WORLD

9.... COMPETITIVE LANDSCAPE

9.1            INTRODUCTION
9.2            HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE ANALYSIS (2018)
9.3            COMPETITIVE SCENARIO

10.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW)*
10.1          MCKESSON CORPORATION
10.2          CARDINAL HEALTH, INC.
10.3          AMERISOURCEBERGEN CORPORATION
10.4          OWENS & MINOR, INC.
10.5          MORRIS & DICKSON CO. L.L.C.
10.6          CURASCRIPT SPECIALTY DISTRIBUTION
10.7          FFF ENTERPRISES, INC.
10.8          MEDLINE INDUSTRIES
10.9          ATTAIN MED, INC.
10.10       DAKOTA DRUG
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.. APPENDIX

LIST OF TABLES

TABLE 1               SERIALIZATION & AGGREGATION REGULATIONS, BY COUNTRY/REGION
TABLE 2               HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 3               PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 4               PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 5               PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTC DRUGS/VITAMINS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 6               PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BRAND-NAME/INNOVATOR DRUGS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 7               PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR GENERIC DRUGS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 8               MEDICAL DEVICE DISTRIBUTION SERVICES MARKET, BY COUNTRY,
2017–2024 (USD BILLION)
TABLE 9               BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 10             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 11             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 12             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR VACCINES, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 13             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR RECOMBINANT PROTEINS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 14             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR BLOOD AND BLOOD PRODUCTS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 15             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 16             HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 17             HEALTHCARE DISTRIBUTION SERVICES MARKET FOR RETAIL PHARMACIES,
BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 18             HEALTHCARE DISTRIBUTION SERVICES MARKET FOR HOSPITAL PHARMACIES,
BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 19             HEALTHCARE DISTRIBUTION SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 20             HEALTHCARE DISTRIBUTION SERVICES MARKET, BY REGION,
2017–2024 (USD BILLION)
TABLE 21             NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET,
BY COUNTRY, 2017–2024 (USD BILLION)
TABLE 22             NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET,
BY END USER, 2017–2024 (USD BILLION)
TABLE 23             NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 24             NORTH AMERICA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION)
TABLE 25             NORTH AMERICA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION)
TABLE 26             US: PHARMACEUTICAL IMPORTS AND EXPORTS (2015)
TABLE 27             US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 28             US: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 29             US: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 30             US: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 31             CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 32             CANADA: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 33             CANADA: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 34             CANADA: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 35             EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY COUNTRY,
2017–2024 (USD BILLION)
TABLE 36             EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 37             EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 38             EUROPE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 39             EUROPE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 40             GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 41             GERMANY: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 42             GERMANY: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 43             GERMANY: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 44             FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 45             FRANCE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 46             FRANCE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 47             FRANCE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 48             UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 49             UK: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 50             UK: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 51             UK: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 52             ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 53             ROE: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 54             ROE: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 55             ROE: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 56             ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER, 2017–2024 (USD BILLION)
TABLE 57             ASIA PACIFIC: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 58             ASIA PACIFIC: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 59             ASIA PACIFIC: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET, BY TYPE, 2017–2024 (USD BILLION)
TABLE 60             ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2017–2024 (USD BILLION)
TABLE 61             ROW: HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2017–2024 (USD BILLION)
TABLE 62             ROW: PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 63             ROW: BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET,
BY TYPE, 2017–2024 (USD BILLION)
TABLE 64             SOLUTION AND SERVICE LAUNCHES, 2016–2019
TABLE 65             AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2016–2019
TABLE 66             ACQUISITIONS, 2016–2019
TABLE 67             EXPANSIONS, 2016–2019

LIST OF FIGURES

FIGURE 1             HEALTHCARE DISTRIBUTION SERVICES MARKET SEGMENTATION
FIGURE 2             HEALTHCARE DISTRIBUTION SERVICES MARKET: RESEARCH METHODOLOGY
FIGURE 3             RESEARCH DESIGN
FIGURE 4             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 5             DATA TRIANGULATION METHODOLOGY
FIGURE 6             HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY TYPE, 2018
FIGURE 7             PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE,
BY TYPE, 2018
FIGURE 8             BIOPHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES MARKET SHARE,
BY TYPE, 2018
FIGURE 9             HEALTHCARE DISTRIBUTION SERVICES MARKET SHARE, BY END USER, 2018
FIGURE 10          GEOGRAPHICAL SNAPSHOT OF THE HEALTHCARE DISTRIBUTION SERVICES MARKET
FIGURE 11          RISING INCIDENCE OF CHRONIC DISEASES AND AVAILABILITY OF R&D INVESTMENTS ARE THE KEY FACTORS DRIVING MARKET GROWTH
FIGURE 12          PHARMACEUTICAL PRODUCT DISTRIBUTION SERVICES SEGMENT DOMINATED THE NORTH AMERICAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018
FIGURE 13          RETAIL PHARMACIES ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN HEALTHCARE DISTRIBUTION SERVICES MARKET IN 2018
FIGURE 14          ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD   33
FIGURE 15          MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION)
FIGURE 16          HEALTHCARE DISTRIBUTION SERVICES MARKET, BY TYPE,
2019 VS. 2024 (USD BILLION)
FIGURE 17          HEALTHCARE DISTRIBUTION SERVICES MARKET, BY END USER,
2019 VS. 2024 (USD BILLION)
FIGURE 18          HEALTHCARE DISTRIBUTION SERVICES MARKET: GEOGRAPHIC SNAPSHOT  65
FIGURE 19          NORTH AMERICA: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT
FIGURE 20          EUROPE: HEALTHCARE DISTRIBUTION SERVICES MARKET SNAPSHOT
FIGURE 21          Y-O-Y GROWTH IN THE GERMAN PHARMACEUTICAL INDUSTRY, 2011–2015
FIGURE 22          ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 23          ROW: MARKET SNAPSHOT
FIGURE 24          MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
FIGURE 25          MCKESSON CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 26          CARDINAL HEALTH: COMPANY SNAPSHOT (2018)
FIGURE 27          AMERISOURCEBERGEN CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 28          OWENS & MINOR: COMPANY SNAPSHOT (2017)

当レポートのプレスリリースは発行されておりません。